Alesi Surgical Ltd

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Alesi Surgical Ltd - overview

Established

2009

Location

Cardiff, -, UK

Primary Industry

Medical Devices & Equipment

About

Alesi Surgical Ltd. specializes in innovative surgical smoke management solutions, enhancing safety and visibility during surgical procedures through its advanced technology, particularly the Ultravision™ system and IonPencil™ device. Founded in Cardiff, UK in 2009, Alesi Surgical Ltd. focuses on developing surgical smoke management technologies.


The company has made 10 significant deals, with its latest funding round occurring on April 22, 2026, raising GBP 7 million, led by IW Capital, with particiaption from IP Group and Mercia Ventures. The CEO, Dominic Griffiths, has a background in advancing healthcare technologies, though specific prior ventures are not detailed. Alesi Surgical specializes in innovative surgical smoke management solutions, primarily through its flagship products, the Ultravision™ system and the IonPencil™. The Ultravision™ system actively eliminates surgical smoke at the point of origin, enhancing visibility during surgeries while minimizing patient carbon dioxide exposure.


This technology uses a unique electrostatic precipitation method to control bioaerosols, thereby improving surgical conditions. The IonPencil™, a world-first device, enables silent, vacuum-free smoke management without traditional evacuators, catering to hospitals and surgical centers, especially in the United States and Europe, where regulatory changes are increasing demand for such technologies. In the most recent fiscal year, Alesi Surgical reported a revenue of GBP 234,167. 50.


The company generates income primarily through direct sales to healthcare institutions that require advanced smoke management solutions, aligning pricing with the high-value nature of their technology. Following the GBP 5 million funding raised in September 2024, Alesi Surgical plans to expand its sales operations in the US market and seek regulatory approvals for its products in Europe and Japan. This funding will facilitate the development of new products and support the company's strategy to enter these key markets efficiently.


Current Investors

Longview Innovation , Development Bank of Wales, Fusion IP

Primary Industry

Medical Devices & Equipment

Sub Industries

Healthcare IT, Surgical Devices

Website

www.alesi-surgical.com

Verticals

HealthTech

Company Stage

Series C

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.